Press coverage about China Life Insurance (NYSE:LFC) has trended somewhat negative recently, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. China Life Insurance earned a news sentiment score of -0.06 on Accern’s scale. Accern also assigned news headlines about the financial services provider an impact score of 45.4876774483162 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the media stories that may have impacted Accern Sentiment’s rankings:
Get China Life Insurance alerts:
Critical Comparison: AXA (AXAHY) & China Life Insurance (LFC) (americanbankingnews.com) Zacks Value Investor Highlights: Apple, Amazon, Alphabet, China Life Insurance and Jacobs Engineering (finance.yahoo.com) China Life Insurance (LFC) Rating Lowered to Sell at Goldman Sachs (americanbankingnews.com) Head to Head Comparison: China Life Insurance (LFC) & The Competition (americanbankingnews.com) Contrasting China Life Insurance (LFC) and Its Competitors (americanbankingnews.com)
China Life Insurance traded up $0.23, hitting $14.32, during midday trading on Friday, MarketBeat Ratings reports. The company’s stock had a trading volume of 454,100 shares, compared to its average volume of 692,520. The company has a current ratio of 8.45, a quick ratio of 8.45 and a debt-to-equity ratio of 0.05. China Life Insurance has a 12 month low of $13.48 and a 12 month high of $17.85. The stock has a market cap of $81.12 billion, a PE ratio of 15.40, a price-to-earnings-growth ratio of 0.49 and a beta of 1.57.
China Life Insurance (NYSE:LFC) last issued its quarterly earnings results on Thursday, March 22nd. The financial services provider reported $0.14 EPS for the quarter. China Life Insurance had a net margin of 6.26% and a return on equity of 12.32%. The firm had revenue of $14.22 billion for the quarter. equities analysts predict that China Life Insurance will post 1.06 EPS for the current fiscal year.
The business also recently declared an annual dividend, which will be paid on Thursday, August 16th. Investors of record on Wednesday, June 13th will be paid a $0.3185 dividend. The ex-dividend date of this dividend is Tuesday, June 12th. This represents a yield of 2.3%. China Life Insurance’s dividend payout ratio is currently 15.05%.
LFC has been the topic of several research reports. Zacks Investment Research cut shares of China Life Insurance from a “buy” rating to a “hold” rating in a research report on Wednesday, January 24th. Macquarie upgraded shares of China Life Insurance from a “neutral” rating to an “outperform” rating and boosted their price target for the stock from $13.49 to $13.85 in a research report on Tuesday, April 24th. Goldman Sachs cut shares of China Life Insurance from a “neutral” rating to a “sell” rating in a research report on Thursday. Nomura upgraded shares of China Life Insurance from a “neutral” rating to a “buy” rating in a research report on Friday, April 20th. Finally, HSBC upgraded shares of China Life Insurance from a “hold” rating to a “buy” rating in a research report on Wednesday, April 4th. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company’s stock. China Life Insurance presently has a consensus rating of “Hold” and an average target price of $14.93.
China Life Insurance Company Profile
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People's Republic of China. The company operates in four segments: Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Business. It offers individual and group life, annuity, accident, and health insurance products, as well as provides pension products.